Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2026-02-27 @ 3:13 AM
Study NCT ID:
NCT05660720
Status:
UNKNOWN
Last Update Posted:
2022-12-21
First Post:
2022-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
Sponsor:
Beijing InnoCare Pharma Tech Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ICP-CL-00120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None